Substance
ID:349163
Names and Identifiers
IUPAC name
5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione hydrochloride
IUPAC Traditional name
pioglitazone hydrochloride
Synonyms
5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloridePioglitazone hydrochloride
Properties
Safety Information
GHS Signal Word
Warning
European Hazard Symbols
Irritant (Xi)GHS Precautionary statements
P305+P351+P338
GHS Hazard statements
H319
Risk Statements
36
GHS Pictograms
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
Safety Statements
26
German water hazard class
3
MSDS Link
Storage Temperature
room temp
Product Information
Empirical Formula (Hill Notation)
C19H20N2O3S · HCl
Purity
≥98% (HPLC)
Physical Property
Solubility
DMSO: ≥10 mg/mL
Apperance
white to off-white powder
Molecule Details
Biochem/physiol Actions
Pioglitazone hydrochloride is a PPARγ agonist and thiazolidinedione (TZD) anti-diabetic. Pioglitazone is a selective agonist of the nuclear receptor peroxisome proliferator-activated receptor γ (PPAR-γ) and to a lesser extent PPAR-α.
Pioglitazone hydrochloride is a PPARγ agonist and thiazolidinedione (TZD) anti-diabetic. Pioglitazone is a selective agonist of the nuclear receptor peroxisome proliferator-activated receptor γ (PPAR-γ) and to a lesser extent PPAR-α.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data